The Aldebert Autopsies · Autopsy No. 2

Bed Bath & Beyond: The Retailer That Bought Itself To Death

For 52 years Bed Bath & Beyond was the biggest specialty home retailer in America. Then it spent $11.7 billion buying back its own stock instead of reinvesting in the business. When it needed the money back, the money was gone. Not stolen. Distributed. To shareholders who called it capital return and management who called it value creation. Then in April 2023, the business filed for bankruptcy carrying $5.2 billion in debt against a balance sheet whose shareholders equity had turned negative.

A store in Springfield, New Jersey. April 2023. The same New Jersey suburb where the first Bed 'n Bath opened in 1971. On the front door, a printed notice. Store closing. Nothing lasts forever. Everything must go. Fifty-two years earlier, two men from a discount chain that was going out of business had walked into that same suburb with $50,000 each and opened a store because they thought retail was moving toward specialty. They were right. For half a century, they were right.

The company they founded is filing for bankruptcy in a New Jersey courtroom the same week that notice goes up. Total funded debt at filing: $5.2 billion. Long-term debt: $1.8 billion. Total shareholders equity: negative $2.8 billion. Three hundred sixty namesake stores still open. One hundred twenty Buybuy Baby stores. Down from a peak of over 1,500 locations. Every one closed by June 30.

The news called it a meme stock story. The news called it an Amazon story. The news called it a pandemic supply chain story.

The doctrine calls it something else.

Between 2004 and 2023, Bed Bath & Beyond spent $11.731 billion buying back its own stock. That number is on file with the SEC. It sits in the 10-K signed by management in February 2023, two months before the bankruptcy petition. It is roughly twice the total debt the company filed bankruptcy with. It is more money than the operating business ever spent on new stores, new logistics infrastructure, or e-commerce combined across the same period. To understand how Bed Bath & Beyond falls, you have to understand what a share buyback actually is, and what nineteen years of them do to the business that pays for them.

This is the rise and fall of Bed Bath & Beyond.

The verdict. Bed Bath & Beyond did not die from the pandemic. It did not die from Amazon. It did not die from Ryan Cohen. It died from a nineteen-year board decision to give the operating cash back to shareholders instead of leaving it in the business. Every quarter that decision compounded. When the business needed the money back, the money was gone. Not stolen. Distributed. To shareholders who called it capital return and management who called it value creation. The buybacks were owner draws in disguise, and the doctrine could have seen it flashing on the biomarker as early as fiscal 2015.

The spiral in the wild

Bed Bath & Beyond ran Cancer 2 for nineteen years. Every quarter of the $11.7 billion buyback program was a quarter of working capital deliberately extracted. Layer 2 drained. Cancer 1 climbed as new debt was taken to fund the extraction. The spiral compounded until fiscal 2022, when total shareholders equity turned negative $2.8 billion. The P&L still showed positive net income for most of the way down.

Read The Two Cancers for the mechanism at the $2 million to $8 million SMB dollar scale where most of the diagnostic record actually sits.

The Rise

Bed Bath & Beyond was not built by a corporate strategist. It was built by two guys who got sick of working at a discount chain that was going out of business.

Their names were Warren Eisenberg and Leonard Feinstein. Both worked in retail management at a discount department store chain called Arlan's. Arlan's was struggling. Eisenberg and Feinstein could see it, they were watching the numbers up close, and they had a thesis about where retail was going next. Department stores were losing to specialty. If you could pick one product category and own it, you could beat the giants. In 1971, they walked out of Arlan's, put up $50,000 each, and opened two 2,000 square foot stores in the New York suburbs. One in Springfield, New Jersey. One in Cedarhurst, Long Island. They called the concept Bed 'n Bath.

The stores worked immediately. Specialty linens. Specialty bath goods. Brands like Cannon, Wamsutta, and Fieldcrest that department stores carried as an afterthought but Bed 'n Bath carried as the entire concept. Add private-label. Add the big blue coupon that would define the brand for the next 40 years. And keep adding stores.

By the late 1980s the name had become Bed Bath & Beyond, because the concept had grown past linens into everything else a home needed. The company went public in 1992. The IPO was priced at $17 a share. Wall Street loved it. The stock ran. By the mid-2000s the company had crossed 1,000 stores. By the peak, over 1,500. Annual revenue over $12 billion. Same-store sales growth every year for 27 consecutive years. Warren and Lenny, as their employees called them, were still in the building.

And underneath the whole thing, the business threw off cash. A lot of cash. Specialty home retail with high inventory turns and low real estate cost per store is a beautiful business when it works. And for 30 years, Bed Bath & Beyond worked. The founders had built one of the most durable specialty retailers in American history. Then they handed it to a management team that decided the highest and best use of the cash was to give it back to shareholders.

The Fracture

To understand what killed Bed Bath & Beyond, you have to understand what a share buyback actually is. And you have to understand that the first one happened almost twenty years before the bankruptcy petition.

The fracture did not happen in 2022 when Ryan Cohen showed up. It did not happen in 2019 when the pandemic hit. It did not happen in 2018 when Amazon overtook the category. It happened in December 2004. That is when Bed Bath & Beyond's board authorized its first share repurchase program.

Between December 2004 and February 2023, the board authorized up to $12.95 billion in share buybacks across a series of programs. And between 2004 and the Chapter 11 filing, the company actually spent $11.731 billion buying back its own stock. That number is on file with the SEC. It sits in the 10-K signed by management in February 2023, two months before the bankruptcy petition.

Read that number twice.

Eleven point seven three one billion dollars. That is roughly the market cap of a mid-cap public company. It is roughly twice the amount of total debt Bed Bath & Beyond carried when it filed for bankruptcy. It is more money than the operating business ever spent on new stores, new logistics infrastructure, or e-commerce combined across the same period.

And it did not all happen in the good years. In fiscal 2015, the company spent $2.25 billion buying back stock. Gross margin that year had already started sliding from a peak of over 40 percent toward the mid-30s. In fiscal 2016, another $1.1 billion. In fiscal 2019, gross margin had fallen to 34.1 percent and operating margin turned negative for the first time. The buybacks continued. In fiscal 2021, in the middle of a pandemic recovery when the business needed every dollar of working capital it could hold, Bed Bath & Beyond spent another $1 billion buying back stock, and they completed the program two years ahead of schedule and called it a win. In February 2022, three months before the CEO was fired and thirteen months before the bankruptcy filing, the company spent another $230 million on an accelerated share repurchase at an average price of $16.04 a share.

Three years later that stock was worth zero.

This is the fracture. Not Ryan Cohen. Not meme stock mania. Not the pandemic. Not the endless CEO changes. The fracture was a nineteen year decision by the board of Bed Bath & Beyond to give the operating cash back to shareholders instead of leaving it in the business. Every quarter that decision compounded. Every dollar of buyback was a dollar that would not be there when the business needed it, and every business eventually needs it.

The Doctrine Overlay

What the buybacks actually were. A stock buyback is not a strategy. It is a distribution. When a public company spends operating cash to repurchase its own shares, it is doing exactly what a small business owner does when he takes a distribution instead of leaving the money in the business. The optics are different. Public company buybacks come with press releases and investor decks and Wall Street analyst upgrades. Small business owner draws show up on a balance sheet line called Distributions to Owner. Underneath the language, the mechanic is identical. Cash the business could have used to fund working capital, reinvest in the store base, modernize logistics, or absorb a bad cycle, leaves the business. Forever. It does not come back when the business needs it. Owners tell themselves the buybacks return capital to shareholders. What they actually do is drain capital from the operating business.

Which MMP sub-layer got starved. All five. Minimum Mandatory Profit is not one number. It is five. Debt service. Working capital. Retirement funding. Owner compensation. Exit strategy. In a public company, retirement funding becomes reinvestment, owner compensation becomes fair-market executive pay, and exit strategy becomes long-term shareholder value. When management spent $11.7 billion on buybacks between 2004 and 2023, it drained the working capital sub-layer, the reinvestment sub-layer, and the long-term shareholder-value sub-layer simultaneously. The business kept operating on the surface. Underneath, the balance sheet was being hollowed out one quarterly buyback at a time. By fiscal 2022, total shareholders equity had turned negative by $2.8 billion. That means the business's liabilities exceeded its assets by nearly three billion dollars. The doctrine has a name for that condition. It is called structural insolvency, and it was the arithmetic result of paying out cash the business would need later.

Which capacity broke. Working Capital Capacity. It is the second of the four capacities Return to Owner reads on every diagnostic. Working Capital Capacity is the cash a business holds to fund the space between committing money and collecting it. In retail, that gap is enormous. Buy the inventory in July for a holiday season that pays in December. Pay the labor before the goods are sold. Pay the rent whether the store is full or empty. A healthy specialty retailer holds enough working capital to survive a bad cycle without emergency financing. Bed Bath & Beyond ran that buffer down for nineteen years and gave the buffer to shareholders. When the pandemic came, when supply chains broke, when Amazon took the customer, when comparable sales dropped 25 percent in a single quarter, the buffer was not there. The business had already spent it. The bankruptcy filing in April 2023 was arithmetic catching up with the buybacks.

Where the diagnostic would have flashed first. Fiscal 2015. The year the company spent $2.25 billion buying back stock while gross margin was already sliding from its peak. A Return to Owner diagnostic run on 2015 numbers would have surfaced a Working Capital Capacity biomarker moving in the wrong direction, a gross margin trajectory bending down, and a capital allocation policy sending record cash to shareholders in a year when reinvestment was already needed. The composite Business Biomarker Index score would have moved from Strong toward Stable, with the trajectory turning red. Nobody read the trajectory. Wall Street analysts called the buyback program shareholder-friendly. The stock rewarded management for the buybacks by trading up. The board authorized more. Every quarter of positive stock reaction to a buyback announcement was a quarter of buffer being spent on optics.

The Ryan Cohen red herring. In March 2022, activist investor Ryan Cohen revealed a 9.8 percent stake in Bed Bath & Beyond through his firm RC Ventures. Cohen wrote a letter to the board demanding change. Sell Buybuy Baby. Cost discipline. Board restructuring. Every subsequent piece of coverage centered on Cohen as the catalyst of the collapse. Cohen was not the catalyst. Cohen was a symptom. When an activist takes a stake in a public company that has spent $11 billion buying back its own stock while its gross margin was collapsing, the activist is not causing the collapse. He is watching it happen and trying to profit from it before it finishes. In August 2022, five months after taking his stake, Cohen sold his entire position and the stock dropped 27 percent in a day. He made money on the trade. The business kept dying. The doctrine reads Cohen not as the villain but as the person who correctly identified that the buyback strategy had left the business with no way to survive.

The Intervention That Could Have Saved It

Stop the buybacks in 2015. The single intervention that would have saved Bed Bath & Beyond was a board decision in fiscal 2015 to end the share repurchase program and redirect the operating cash into the business. Gross margin was already sliding. Amazon was already taking category share. Store productivity was already softening. Every dollar that went to buybacks in 2015, 2016, and 2017 could have funded logistics infrastructure to compete with Amazon, private-label expansion to protect margin, and modernization of the store base to give customers a reason to walk in. None of that would have been glamorous. None of it would have moved the stock the way a buyback announcement did. All of it would have kept the business alive.

The question no board member asked. Before authorizing the fiscal 2015 buyback, someone in the board meeting should have asked one question. What does the Working Capital Capacity biomarker look like on the current gross margin trajectory if we take another $2.25 billion out of the business? What is the year we run out of buffer if this trend continues? Are we returning capital to shareholders or are we depriving the operating business of the capital it needs to fight the fight it is already in? Nobody asked. The board approved the buyback. The CEO issued a press release. The analysts upgraded the stock. The doctrine question would have been decisive. It was not asked because buybacks are the language Wall Street speaks, and the language does not accommodate operating reality.

The intervention that could have worked in 2019. By fiscal 2019, gross margin had fallen to 34.1 percent and operating margin turned negative for the first time. A responsible board would have stopped every buyback dollar and used the operating cash flow to rebuild working capital. Instead the company kept buying. Fiscal 2019: $148 million in buybacks. Fiscal 2021: a full $1 billion. Fiscal 2022: another $589 million. That is over $1.7 billion of buffer spent while the business was structurally insolvent. Any of that money, held in the operating account, would have bought the business two more years to find a strategic acquirer, sell Buybuy Baby at a real price, or execute an orderly reorganization outside of bankruptcy court. None of it existed by the time the executive team went looking for it.

The Lesson For Small Business Owners

You are not the board of Bed Bath & Beyond. You are not Wall Street. You are not a public company CFO. But the pattern that killed Bed Bath & Beyond is running in small businesses right now. Every day. And nobody is calling it what it actually is.

Owner draws are buybacks. Buybacks are owner draws. The most common small-business version of the Bed Bath & Beyond pattern is the owner who takes distributions above his fair-market compensation number, calls the difference profit sharing or capital return, and does not leave the money in the business. In public company language it is called returning capital to shareholders. In small business language it is called paying yourself. The mechanic is identical. Cash the business could use to fund working capital, buffer a bad quarter, or absorb a supply-chain shock, leaves the business. It goes to the owner as a distribution. It does not come back when the business needs it, because the business needs it precisely when the owner has already spent it.

The line between compensation and extraction. Fair-market owner compensation is the fourth sub-layer of Minimum Mandatory Profit. It is the number the business would have to pay a non-owner operator to do the same job at market rates. Anything the owner draws above that number is extraction, not compensation, and it drains the working capital sub-layer of MMP the same way buybacks drained Bed Bath & Beyond. Extraction feels like reward when the business is running above MMP. It feels like theft when the business needs the money back and the money is not there.

The trap is the timing. The most dangerous owner draws happen in the best years. Sales are up. Cash is flowing. The owner tells himself he is being smart about capital allocation. He is being tax-efficient. He is rewarding the risk he took. In doctrine terms, he is spending the working capital buffer that will not exist in the next bad year. Every business has bad years. Every business has supply-chain shocks, competitive attacks, and category compression. The businesses that survive the shocks are the ones that held cash through the good years. The businesses that die are the ones that gave the good-year cash back to the owner.

The move this week. Look at the last three fiscal years of owner distributions from the business. Not W-2 wages. Distributions. K-1 income beyond fair-market executive pay. Real-estate rent paid to the owner personally. Anything above the fair-market compensation for the job the owner actually does. Add the numbers. That is the buyback program of your business. Then run Return to Owner to see where the Working Capital Capacity biomarker actually sits today, after the distributions have already left the business. If the number is below the industry standard for your category, the diagnostic that Bed Bath & Beyond never ran is available to you now.

The Postscript

Bed Bath & Beyond emerged from bankruptcy as an intellectual property shell. Overstock won the IP auction for $21.5 million in June 2023 and rebranded itself under the Bed Bath & Beyond name to capture the residual brand recognition. The 480 physical stores are gone. Buybuy Baby is gone. Warren Eisenberg died in December 2022, five months before the bankruptcy filing of the company he built. Leonard Feinstein retired years earlier. Neither of them ever authorized a share buyback program. Between them they owned the stores for 33 years before going public, and in those 33 years the business grew from two 2,000 square foot suburbs to a national chain. Every buyback dollar was authorized after they were no longer running the company.

The doctrine reads all of it as a single sentence. A business that spent nineteen years giving its operating cash to shareholders had no operating cash left when it needed to survive a hard cycle. Every owner of a small business who reads this Autopsy should ask whether any distribution pattern in their own business has the same shape.

Jay Aldebert
About the author

Jay Aldebert · Profit Architect

Jay Aldebert is the creator of the Aldebert Financial Ecosystem. Return to Owner. Layer Cake. Minimum Mandatory Profit. The Business Biomarker Index. The Aldebert Autopsies apply the same diagnostic framework to public business collapses, on the same numbers that were available at the time of the original decision.

Do not spend the buffer.

Bed Bath & Beyond spent $11.7 billion of its own working capital buffer over nineteen years. When it needed the buffer back, the buffer was gone. Return to Owner reads eleven proprietary Business Biomarkers in one pass on your actual numbers, including the specific Working Capital Capacity number that decides whether your business survives its next hard cycle.

Find My Leak
Preferred on Google

See more of this work in your Google feed.

Add jayaldebert.com as a Preferred Source. Your Top Stories, Discover, and AI Overviews will surface Aldebert diagnostics ahead of the accountants and coaches trying to sound like them.

Add as Preferred Source